Drug addiction is common disorder its tolerance is also a main difficulty including antibiotic and anti physcotic tolerance topic includes basics concepts related to tolerance and its mechanism
Unit 3 Drugs Affecting PNS (As per PCI syllabus)Mirza Anwar Baig
This document provides an overview of a lecture on drugs acting on the autonomic nervous system. It discusses the autonomic neurotransmission and classification of drugs into parasympathomimetics, parasympatholytics, sympathomimetics, and sympatholytics. Specific drugs discussed in detail include direct-acting cholinergic agonists like acetylcholine and indirect-acting cholinergic agonists like anticholinesterase agents. Anticholinergic drugs like atropine are also summarized in terms of their mechanisms and therapeutic uses.
1. Metabolism, or biotransformation, is the process by which enzymes convert lipid-soluble compounds into water-soluble compounds so they can be excreted from the body.
2. The major site of drug metabolism is the liver, through phase I (functionalization) and phase II (conjugation) reactions. Phase I reactions involve oxidation, reduction, and hydrolysis, while phase II reactions conjugate compounds to make them more hydrophilic through glucuronidation, methylation, sulfation, and other processes.
3. Cytochrome P450 enzymes and UDP-glucuronyl transferases are among the most important enzyme families involved in drug metabolism. Metabolism can
Neurohumoral transmission in CNS-
The term neurohumoral transmission designates the transfer of a nerve impulse from a presynaptic to a postsynaptic neuron by means of a humoral agent e.g. a biogenic amine, an amino acid or a peptide.
Sympatholytics, also known as adrenergic antagonists or blocking agents, work in opposition to adrenergic agents by blocking alpha and beta receptor sites. They are classified based on the type of adrenergic receptor they block, including alpha1, alpha2, beta1, beta2, and beta3 receptors. Common alpha blockers include phenoxybenzamine, ergot alkaloids, phentolamine, tolazoline, prazosin, terazosin, doxazosin, and tamsulosin. Common beta blockers mentioned include propanolol, acetabutolol, atenolol, betaxolol, carvedilol, metoprol
This document provides an overview of parasympathomimetic agents or cholinergic drugs. It discusses the organization of the nervous system and types of cholinergic receptors. Cholinergic drugs are classified as directly acting or indirectly acting. Directly acting drugs like choline esters and pilocarpine directly bind to muscarinic and nicotinic receptors. Indirectly acting drugs like physostigmine and neostigmine inhibit acetylcholinesterase and prolong the action of acetylcholine. These drugs have therapeutic uses in conditions like myasthenia gravis and glaucoma. Organophosphate poisoning is also discussed which occurs due to inhibition of acetylcholinesterase.
Unit 3 Drugs Affecting PNS (As per PCI syllabus)Mirza Anwar Baig
This document provides an overview of a lecture on drugs acting on the autonomic nervous system. It discusses the autonomic neurotransmission and classification of drugs into parasympathomimetics, parasympatholytics, sympathomimetics, and sympatholytics. Specific drugs discussed in detail include direct-acting cholinergic agonists like acetylcholine and indirect-acting cholinergic agonists like anticholinesterase agents. Anticholinergic drugs like atropine are also summarized in terms of their mechanisms and therapeutic uses.
1. Metabolism, or biotransformation, is the process by which enzymes convert lipid-soluble compounds into water-soluble compounds so they can be excreted from the body.
2. The major site of drug metabolism is the liver, through phase I (functionalization) and phase II (conjugation) reactions. Phase I reactions involve oxidation, reduction, and hydrolysis, while phase II reactions conjugate compounds to make them more hydrophilic through glucuronidation, methylation, sulfation, and other processes.
3. Cytochrome P450 enzymes and UDP-glucuronyl transferases are among the most important enzyme families involved in drug metabolism. Metabolism can
Neurohumoral transmission in CNS-
The term neurohumoral transmission designates the transfer of a nerve impulse from a presynaptic to a postsynaptic neuron by means of a humoral agent e.g. a biogenic amine, an amino acid or a peptide.
Sympatholytics, also known as adrenergic antagonists or blocking agents, work in opposition to adrenergic agents by blocking alpha and beta receptor sites. They are classified based on the type of adrenergic receptor they block, including alpha1, alpha2, beta1, beta2, and beta3 receptors. Common alpha blockers include phenoxybenzamine, ergot alkaloids, phentolamine, tolazoline, prazosin, terazosin, doxazosin, and tamsulosin. Common beta blockers mentioned include propanolol, acetabutolol, atenolol, betaxolol, carvedilol, metoprol
This document provides an overview of parasympathomimetic agents or cholinergic drugs. It discusses the organization of the nervous system and types of cholinergic receptors. Cholinergic drugs are classified as directly acting or indirectly acting. Directly acting drugs like choline esters and pilocarpine directly bind to muscarinic and nicotinic receptors. Indirectly acting drugs like physostigmine and neostigmine inhibit acetylcholinesterase and prolong the action of acetylcholine. These drugs have therapeutic uses in conditions like myasthenia gravis and glaucoma. Organophosphate poisoning is also discussed which occurs due to inhibition of acetylcholinesterase.
This document discusses pharmacodynamics and the mechanisms of drug action. It explains that pharmacodynamics is the study of how drugs act on the body and their effects, focusing on drug-receptor interactions and the biochemical and physiological impacts of drugs. Various mechanisms are described, including stimulation, depression, irritation, and replacement effects. The key mechanisms of drug action are interactions with receptors, ion channels, enzymes, and transporter proteins. Different types of receptors - ligand-gated ion channels, G-protein coupled receptors, kinase-linked receptors, and nuclear receptors - are also outlined.
This document discusses adrenergic antagonists, which are drugs that block adrenergic receptors to inhibit the functions of epinephrine, norepinephrine, and dopamine. It classifies them as alpha or beta blockers and provides examples of each. Key drugs discussed include tolazoline, phentolamine, phenoxybenzamine, prazosin, dihydroergotamine, methysergide, propranolol, metoprolol, atenolol, betaxolol, esmolol, metaprolol, and carvedilol. Their structures, mechanisms of action, and clinical uses for conditions like hypertension and cardiac issues are summarized. The synthesis of tolazoline and
PARASYMPATHOMIMETIC DRUGS Classification and SAR.pptxJasmine Chaudhary
This document discusses parasympathomimetic drugs, also known as cholinergic drugs, which mimic the action of acetylcholine in the body. It describes two types of cholinergic drugs: direct-acting drugs that stimulate cholinergic receptors, and indirect-acting drugs that inhibit the acetylcholinesterase enzyme and increase acetylcholine levels. The document provides details on the classification, structure-activity relationships, mechanisms of action, effects, and examples of both types of cholinergic drugs.
A brief presentation about the transport of drugs across the cell membrane including the many mechanisms and various transporters and a brief overview of the ABC and SLC superfamily of transporters.
This document discusses drug elimination kinetics. It describes the main routes of drug excretion from the body, including hepatic excretion through bile and renal excretion through glomerular filtration and tubular secretion/reabsorption. The kinetics of drug elimination are explained, including plasma half-life, repeated dosing to achieve steady state concentrations, and target level strategies using loading and maintenance doses. The principles of first-order and zero-order elimination, as well as therapeutic drug monitoring, are also outlined.
ANTI ALZHEIMER'S AGENTS / DRUGS USED IN THE TREATMENT OF ALZHEIMER'S DISEASEKameshwaran Sugavanam
This document discusses drugs used to treat Alzheimer's disease. It focuses on cholinergic activators like rivastigmine and donepezil, which work by inhibiting the breakdown of acetylcholine in the brain to increase levels of this neurotransmitter that is deficient in Alzheimer's patients. It also discusses memantine, an NMDA receptor antagonist that blocks glutamate receptors and protects nerve cells from damage. Common side effects of these drugs include nausea, diarrhea, vomiting and headaches. The document provides details on the mechanisms and effects of rivastigmine and memantine as two major drug classes used to treat symptoms of Alzheimer's disease.
Cholinergic receptors and its modulators(agonists, antagonists etc)Asif Hussain
This document summarizes the autonomic nervous system and its parasympathetic and sympathetic divisions. It describes the cholinergic and muscarinic receptors involved in parasympathetic signaling and their roles. Anticholinergic drugs like atropine that block muscarinic receptors are discussed. Their clinical uses to treat conditions like asthma, Parkinson's disease, and GI disorders are highlighted. The document also notes side effects of anticholinergics and drug interactions to watch out for. Ganglion blocking drugs are briefly mentioned at the end.
UNIT III_cholinergic neurotransmitter agonistSONALI PAWAR
The document discusses cholinergic neurotransmitters and parasympathomimetic agents. It begins by providing an overview of acetylcholine as the principal neurotransmitter of the parasympathetic nervous system. It then discusses the classification of parasympathomimetic agents into direct-acting agents like acetylcholine and indirect-acting agents like cholinesterase inhibitors. The document also covers the structure and mechanisms of several parasympathomimetic drugs including carbachol, bethanechol, methacholine, pilocarpine, physostigmine, and neostigmine. It concludes by describing the cholinergic receptors, muscarinic and nicotinic, and their distributions in the body.
This document discusses drug elimination, which involves biotransformation (metabolism) and excretion of drugs from the body. It describes zero-order and first-order elimination kinetics, drug metabolism pathways including phase I and II reactions, and factors that influence renal excretion of drugs such as physicochemical properties and plasma concentration. Renal clearance is defined as the volume of plasma cleared of drug per unit time by the kidneys. Non-renal routes of excretion include biliary, pulmonary, dermal and gastrointestinal excretion.
Biosynthesis and catabolism of acetylcholine by Dheeraj gargDheeraj Aggarwal
Acetylcholine (ACh) is an organic chemical that functions in the brain and body of many types of animals (and humans) as a neurotransmitter—a chemical message released by nerve cells to send signals to other cells, such as neurons, muscle cells and gland cells.
This document discusses drug metabolism and biotransformation. It begins by introducing drug metabolizing enzymes, which convert drugs into different metabolites through Phase I and Phase II reactions. Phase I reactions introduce or modify functional groups on drugs to make them more polar and able to undergo Phase II conjugation reactions. Cytochrome P450 enzymes are a major family of enzymes involved in Phase I oxidations. The document provides examples of different types of drug metabolism and how metabolites can have different pharmacological effects than the parent drug.
Drug used in Parkinson,Alzheimer and CNS stimulantsRajkumar Kumawat
This document discusses several central nervous system (CNS) stimulants. It describes how Parkinsonism involves slowed movement and tremors, and can be treated with drugs that increase dopamine like levodopa. Alzheimer's disease causes dementia and memory loss, and is treated with cholinergic drugs. CNS stimulants temporarily improve mental and physical function and include xanthines like caffeine, amphetamines, and methylphenidate. Other stimulants discussed are pentylenetetrazol, nikethamide, strychnine, and lobeline.
This document summarizes various classes of analgesic drugs including narcotics/opioids, non-narcotics, and specific drugs within each class. It describes the mechanism of action, uses, and side effects of common opioid analgesics like morphine, methadone, fentanyl, and non-opioid analgesics like acetaminophen. It also discusses opioid receptor types and how different drugs can act as agonists, antagonists, or mixed agonist-antagonists at these receptors.
This document summarizes parasympathomimetics (cholinergic agonists). It discusses how the parasympathetic nervous system uses acetylcholine as a neurotransmitter and how cholinergic agonists mimic acetylcholine's actions. It classifies cholinergic agonists into direct-acting and indirect-acting types. Direct agonists bind receptors, while indirect agonists inhibit acetylcholinesterase to increase acetylcholine levels. Examples of both types are provided along with their structures, mechanisms of action, and uses. The document also covers acetylcholine synthesis and catabolism as well as structure-activity relationships of parasympathomimetics.
The document discusses acetylcholine (ACh), a neurotransmitter that is secreted by neurons in the nervous system. ACh acts at neuromuscular junctions and is involved in functions like muscle contraction. It is broken down by the enzyme acetylcholinesterase. There are two main types of ACh receptors: nicotinic and muscarinic. Disorders like myasthenia gravis and glaucoma involve issues with ACh signaling. Inhibitors of acetylcholinesterase are used to treat conditions by prolonging the actions of ACh.
Drug dependence refers to someone feeling like they cannot function normally without the use of the substance.
It is a state in which use of drugs for personal satisfaction is accorded a higher priority than other basic needs, often in the face of known risks to health.
Drugs capable of altering mood and feelings are liable to repetitive use to derive euphoria.
Psychological dependence
It is developed when the individual believes that optimal state of wellbeing is achieved only through the actions of the drug.
It may start as liking for the drug effects and may progress to compulsive drug use in some individuals who then lose control over the use of the drug.
The intensity of psychological dependence may vary from desire to craving
Physical dependence
It is a sign of addiction.
It is a condition in which a person takes a drug over time, and unpleasant physical symptoms occur if the drug is suddenly stopped or taken in smaller doses.
Discontinuation of the drug results in a characteristic withdrawal (abstinence) syndrome.
It causes adaptation of the nervous system to function normally only in the presence of the drug, hence also called ‘neuroadaptation’
Ex: opioids, barbiturates and other CNS depressants including alcohol and benzodiazepines. (dependence + addiction)
Stimulant drugs, e.g. amphetamines, cocaine produce little or no physical dependence (causes more addiction + less dependence)
ADDICTION
Also called “substance use disorder”
It is a neuropsychological disorder characterized by a persistent and intense urge to use a drug or engage in a behavior that produces natural reward, despite substantial harm and other negative consequences.
Procuring the drug and using it takes precedence over other activities.
Repetitive drug use often alters brain function and weakens self-control.
Drug addiction increases the levels of dopamine (control the brain’s reward and pleasure centers)
These increased levels of dopamine create feelings of pleasure and euphoria.
Examples of drug addictions include alcoholism, cannabis addiction, amphetamine addiction, cocaine addiction, nicotine addiction, opioid addiction, and etc.
Effects Of Drug Addiction
Changes in appetite, body temperature and sleeping patterns
Wild mood swings, anxiety, paranoia, depression, and violence
Heart rate irregularities, heart attack
Hallucinations
Confusions
Kidney and liver damage
Abdominal pain, vomiting, constipation, diarrhoea
Seizures, stroke
DRUG ALLERGY
Drug Allergies occur when your immune system reacts to a drug or a metabolite of drug, that usually doesn't cause a reaction in most people.
It is an immunologically mediated reaction producing stereotype symptoms which are unrelated to the pharmacodynamic profile of the drug
Generally occur even with much smaller doses of the drug.
This is also called drug hypersensitivity.
The target organs primarily affected in drug allergy are
Skin, Airways, Blood vessels / Blood and Gastrointestinal tract
Has information about - Drug tolerance - definition, types, sub-types, it's examples; cross tolerance; tachyphylaxis; Drug intolerance - examples; analgesics tolerance
This document discusses pharmacodynamics and the mechanisms of drug action. It explains that pharmacodynamics is the study of how drugs act on the body and their effects, focusing on drug-receptor interactions and the biochemical and physiological impacts of drugs. Various mechanisms are described, including stimulation, depression, irritation, and replacement effects. The key mechanisms of drug action are interactions with receptors, ion channels, enzymes, and transporter proteins. Different types of receptors - ligand-gated ion channels, G-protein coupled receptors, kinase-linked receptors, and nuclear receptors - are also outlined.
This document discusses adrenergic antagonists, which are drugs that block adrenergic receptors to inhibit the functions of epinephrine, norepinephrine, and dopamine. It classifies them as alpha or beta blockers and provides examples of each. Key drugs discussed include tolazoline, phentolamine, phenoxybenzamine, prazosin, dihydroergotamine, methysergide, propranolol, metoprolol, atenolol, betaxolol, esmolol, metaprolol, and carvedilol. Their structures, mechanisms of action, and clinical uses for conditions like hypertension and cardiac issues are summarized. The synthesis of tolazoline and
PARASYMPATHOMIMETIC DRUGS Classification and SAR.pptxJasmine Chaudhary
This document discusses parasympathomimetic drugs, also known as cholinergic drugs, which mimic the action of acetylcholine in the body. It describes two types of cholinergic drugs: direct-acting drugs that stimulate cholinergic receptors, and indirect-acting drugs that inhibit the acetylcholinesterase enzyme and increase acetylcholine levels. The document provides details on the classification, structure-activity relationships, mechanisms of action, effects, and examples of both types of cholinergic drugs.
A brief presentation about the transport of drugs across the cell membrane including the many mechanisms and various transporters and a brief overview of the ABC and SLC superfamily of transporters.
This document discusses drug elimination kinetics. It describes the main routes of drug excretion from the body, including hepatic excretion through bile and renal excretion through glomerular filtration and tubular secretion/reabsorption. The kinetics of drug elimination are explained, including plasma half-life, repeated dosing to achieve steady state concentrations, and target level strategies using loading and maintenance doses. The principles of first-order and zero-order elimination, as well as therapeutic drug monitoring, are also outlined.
ANTI ALZHEIMER'S AGENTS / DRUGS USED IN THE TREATMENT OF ALZHEIMER'S DISEASEKameshwaran Sugavanam
This document discusses drugs used to treat Alzheimer's disease. It focuses on cholinergic activators like rivastigmine and donepezil, which work by inhibiting the breakdown of acetylcholine in the brain to increase levels of this neurotransmitter that is deficient in Alzheimer's patients. It also discusses memantine, an NMDA receptor antagonist that blocks glutamate receptors and protects nerve cells from damage. Common side effects of these drugs include nausea, diarrhea, vomiting and headaches. The document provides details on the mechanisms and effects of rivastigmine and memantine as two major drug classes used to treat symptoms of Alzheimer's disease.
Cholinergic receptors and its modulators(agonists, antagonists etc)Asif Hussain
This document summarizes the autonomic nervous system and its parasympathetic and sympathetic divisions. It describes the cholinergic and muscarinic receptors involved in parasympathetic signaling and their roles. Anticholinergic drugs like atropine that block muscarinic receptors are discussed. Their clinical uses to treat conditions like asthma, Parkinson's disease, and GI disorders are highlighted. The document also notes side effects of anticholinergics and drug interactions to watch out for. Ganglion blocking drugs are briefly mentioned at the end.
UNIT III_cholinergic neurotransmitter agonistSONALI PAWAR
The document discusses cholinergic neurotransmitters and parasympathomimetic agents. It begins by providing an overview of acetylcholine as the principal neurotransmitter of the parasympathetic nervous system. It then discusses the classification of parasympathomimetic agents into direct-acting agents like acetylcholine and indirect-acting agents like cholinesterase inhibitors. The document also covers the structure and mechanisms of several parasympathomimetic drugs including carbachol, bethanechol, methacholine, pilocarpine, physostigmine, and neostigmine. It concludes by describing the cholinergic receptors, muscarinic and nicotinic, and their distributions in the body.
This document discusses drug elimination, which involves biotransformation (metabolism) and excretion of drugs from the body. It describes zero-order and first-order elimination kinetics, drug metabolism pathways including phase I and II reactions, and factors that influence renal excretion of drugs such as physicochemical properties and plasma concentration. Renal clearance is defined as the volume of plasma cleared of drug per unit time by the kidneys. Non-renal routes of excretion include biliary, pulmonary, dermal and gastrointestinal excretion.
Biosynthesis and catabolism of acetylcholine by Dheeraj gargDheeraj Aggarwal
Acetylcholine (ACh) is an organic chemical that functions in the brain and body of many types of animals (and humans) as a neurotransmitter—a chemical message released by nerve cells to send signals to other cells, such as neurons, muscle cells and gland cells.
This document discusses drug metabolism and biotransformation. It begins by introducing drug metabolizing enzymes, which convert drugs into different metabolites through Phase I and Phase II reactions. Phase I reactions introduce or modify functional groups on drugs to make them more polar and able to undergo Phase II conjugation reactions. Cytochrome P450 enzymes are a major family of enzymes involved in Phase I oxidations. The document provides examples of different types of drug metabolism and how metabolites can have different pharmacological effects than the parent drug.
Drug used in Parkinson,Alzheimer and CNS stimulantsRajkumar Kumawat
This document discusses several central nervous system (CNS) stimulants. It describes how Parkinsonism involves slowed movement and tremors, and can be treated with drugs that increase dopamine like levodopa. Alzheimer's disease causes dementia and memory loss, and is treated with cholinergic drugs. CNS stimulants temporarily improve mental and physical function and include xanthines like caffeine, amphetamines, and methylphenidate. Other stimulants discussed are pentylenetetrazol, nikethamide, strychnine, and lobeline.
This document summarizes various classes of analgesic drugs including narcotics/opioids, non-narcotics, and specific drugs within each class. It describes the mechanism of action, uses, and side effects of common opioid analgesics like morphine, methadone, fentanyl, and non-opioid analgesics like acetaminophen. It also discusses opioid receptor types and how different drugs can act as agonists, antagonists, or mixed agonist-antagonists at these receptors.
This document summarizes parasympathomimetics (cholinergic agonists). It discusses how the parasympathetic nervous system uses acetylcholine as a neurotransmitter and how cholinergic agonists mimic acetylcholine's actions. It classifies cholinergic agonists into direct-acting and indirect-acting types. Direct agonists bind receptors, while indirect agonists inhibit acetylcholinesterase to increase acetylcholine levels. Examples of both types are provided along with their structures, mechanisms of action, and uses. The document also covers acetylcholine synthesis and catabolism as well as structure-activity relationships of parasympathomimetics.
The document discusses acetylcholine (ACh), a neurotransmitter that is secreted by neurons in the nervous system. ACh acts at neuromuscular junctions and is involved in functions like muscle contraction. It is broken down by the enzyme acetylcholinesterase. There are two main types of ACh receptors: nicotinic and muscarinic. Disorders like myasthenia gravis and glaucoma involve issues with ACh signaling. Inhibitors of acetylcholinesterase are used to treat conditions by prolonging the actions of ACh.
Drug dependence refers to someone feeling like they cannot function normally without the use of the substance.
It is a state in which use of drugs for personal satisfaction is accorded a higher priority than other basic needs, often in the face of known risks to health.
Drugs capable of altering mood and feelings are liable to repetitive use to derive euphoria.
Psychological dependence
It is developed when the individual believes that optimal state of wellbeing is achieved only through the actions of the drug.
It may start as liking for the drug effects and may progress to compulsive drug use in some individuals who then lose control over the use of the drug.
The intensity of psychological dependence may vary from desire to craving
Physical dependence
It is a sign of addiction.
It is a condition in which a person takes a drug over time, and unpleasant physical symptoms occur if the drug is suddenly stopped or taken in smaller doses.
Discontinuation of the drug results in a characteristic withdrawal (abstinence) syndrome.
It causes adaptation of the nervous system to function normally only in the presence of the drug, hence also called ‘neuroadaptation’
Ex: opioids, barbiturates and other CNS depressants including alcohol and benzodiazepines. (dependence + addiction)
Stimulant drugs, e.g. amphetamines, cocaine produce little or no physical dependence (causes more addiction + less dependence)
ADDICTION
Also called “substance use disorder”
It is a neuropsychological disorder characterized by a persistent and intense urge to use a drug or engage in a behavior that produces natural reward, despite substantial harm and other negative consequences.
Procuring the drug and using it takes precedence over other activities.
Repetitive drug use often alters brain function and weakens self-control.
Drug addiction increases the levels of dopamine (control the brain’s reward and pleasure centers)
These increased levels of dopamine create feelings of pleasure and euphoria.
Examples of drug addictions include alcoholism, cannabis addiction, amphetamine addiction, cocaine addiction, nicotine addiction, opioid addiction, and etc.
Effects Of Drug Addiction
Changes in appetite, body temperature and sleeping patterns
Wild mood swings, anxiety, paranoia, depression, and violence
Heart rate irregularities, heart attack
Hallucinations
Confusions
Kidney and liver damage
Abdominal pain, vomiting, constipation, diarrhoea
Seizures, stroke
DRUG ALLERGY
Drug Allergies occur when your immune system reacts to a drug or a metabolite of drug, that usually doesn't cause a reaction in most people.
It is an immunologically mediated reaction producing stereotype symptoms which are unrelated to the pharmacodynamic profile of the drug
Generally occur even with much smaller doses of the drug.
This is also called drug hypersensitivity.
The target organs primarily affected in drug allergy are
Skin, Airways, Blood vessels / Blood and Gastrointestinal tract
Has information about - Drug tolerance - definition, types, sub-types, it's examples; cross tolerance; tachyphylaxis; Drug intolerance - examples; analgesics tolerance
- Drugs vary in their capacity to produce pleasant feelings and reinforcement, which increases the likelihood of repeated use and abuse. The effects of drugs are influenced by agent/drug factors like their pharmacokinetic and pharmacodynamic properties, as well as host/user factors like genetics. Repeated drug use can lead to tolerance through pharmacokinetic changes like metabolism or pharmacodynamic changes in receptors. Abrupt discontinuation of chronic drug use can produce withdrawal symptoms and physical dependence. Treatment for dependence includes gradual drug reduction or maintenance therapies.
ADR refers to adverse drug reactions, which are unintended effects that occur at standard doses used in humans. Some key points about ADRs include:
1. ADRs can be predictable or unpredictable, dose-dependent or independent. Predictable ADRs include toxicity from overdose or side effects from standard doses.
2. Types of ADRs include toxicity, intolerance, side effects, idiosyncrasy, drug allergy, chronic effects, end of treatment effects, delayed effects, and fetal effects.
3. Drug allergy is an immunologically mediated reaction that is unrelated to the drug's pharmacological effects. It requires prior sensitization and can cause various symptoms.
This document discusses adverse drug reactions and drug interactions. It defines an adverse drug reaction as an unintended, harmful response to a drug. Types of adverse reactions include side effects, toxic effects, intolerance, idiosyncrasy, allergic reactions, and iatrogenic diseases. Drug interactions occur when one drug alters the effects of another drug through pharmacokinetic or pharmacodynamic mechanisms. Pharmacokinetic interactions involve absorption, distribution, metabolism and excretion, while pharmacodynamic interactions involve drugs acting on the same receptors. The document emphasizes the importance of understanding adverse reactions and interactions to ensure safe drug use.
Pharmacology is a branch of medicine, biology and pharmaceutical sciences concerned with drug or medication action, where a drug may be defined as any artificial, natural, or endogenous molecule which exerts a biochemical or physiological effect on the cell, tissue, organ, or organism.
This document provides an overview of pharmacology and drug development. It defines key terms like pharmacology, pharmacy, pharmacotherapy, pharmacokinetics, and pharmacodynamics. It describes the stages of drug development from pre-clinical trials to phase I-IV clinical trials. It also discusses sources of drugs like plants, microorganisms, and synthetic chemicals. The goal is to educate on properly administering drugs to patients.
Simplified notes for all those struggling to grasp the pharmacological concepts .
These are self help notes that go straight to the point hence making medicine so simple you'd want to major further.
This document provides an overview of pharmacology and key terminology. It discusses:
1) Definitions of pharmacology, pharmacy, pharmacotherapy and related terms.
2) Key terminology including pharmacokinetics, pharmacodynamics, pharmacogenetics, and drug interactions.
3) The processes of drug absorption, distribution, metabolism and excretion as well as factors that influence absorption.
4) Sources of drugs including plants, animals, inorganic sources and synthetic sources. Routes of drug administration and the two major methods of dispensing drugs are also covered.
PHARMACOLOGY ..........ALL NOTES BY KKEANkkean6089
This document provides an overview of pharmacology and drug development. It defines key terms like pharmacology, pharmacy, and pharmacokinetics. It describes the process of drug development including pre-clinical trials and phases I-IV of clinical trials. It also discusses sources of drugs including plants, microorganisms, and synthetic chemicals. Adverse drug reactions like allergic reactions, tolerance, and dependence are explained. The goal of pharmacology is to administer drugs professionally and understand their mechanisms of action, interactions, and safe use.
The document discusses various types of adverse drug reactions (ADRs) and events. It defines an ADR as any noxious change suspected to be caused by a drug taken at normal doses, and an adverse drug event as any untoward occurrence during treatment that may not be causally related. It describes types of ADRs including dose-related type A reactions, unpredictable type B reactions, chronic type C reactions, and withdrawal type E reactions. It also discusses factors influencing ADRs, grading of severity, classifications, mechanisms of hypersensitivity reactions, pharmacovigilance, and prevention of adverse effects.
Self-medication refers to treating oneself without a doctor's guidance and can have benefits like quick relief but also significant dangers. Dangers include incorrect diagnosis, complications from improper use of medications, drug resistance, addiction, poisoning, and drug-drug interactions. Prescriptions from doctors are important because they are tailored to each individual case and ensure proper dosing. Drug abuse refers to inappropriate use for non-medical purposes and can progress to drug dependence over time as tolerance develops. Dependence involves both physical and psychological components and requires gradual withdrawal and other treatments.
Posology is the science of determining drug doses. The optimal dose varies between individuals due to factors like age, health, weight, drug interactions, and rate of drug elimination from the body. Elderly and children typically require lower doses than adults. Drug effects also depend on route of administration, time of administration, environmental factors, and presence of disease. Drug interactions like additive effects, synergism, antagonism, and tolerance further complicate determining proper dosages.
Pharmacodynamics studies how drugs act on the body and their mechanisms of action. There are two types of pharmacological effects - main effects which are therapeutic, and adverse effects which are unwanted. Drugs can act through receptor mechanisms, by influencing enzymes or ion channels, or through transport systems. Their effects depend on factors like chemical structure, dose, and individual variability. Interactions between drugs can cause synergism, where effects are enhanced, or antagonism, where one drug reduces another's effects. Careful consideration of benefits and risks is needed when using drugs.
This document introduces key concepts in pharmacology. It defines drugs, pharmacology, clinical pharmacology, and therapeutics. An ideal drug is effective, safe, and selective, but in reality no drug is ideal as all can cause harm and have side effects. The objective of drug therapy is to provide maximum benefit with minimum harm by considering factors like administration, pharmacokinetics, pharmacodynamics, and individual patient variations.
This document introduces key concepts in pharmacology. It defines drug, pharmacology, clinical pharmacology, and therapeutics. An ideal drug is effective, safe, and selective, but no drug is truly ideal. The objective of drug therapy is to provide maximum benefit with minimum harm. How individuals respond depends on administration, pharmacokinetics, pharmacodynamics, and individual variations.
Factors modifying drug action by SandipSandip Maity
This document discusses various factors that can modify drug action in the human body. It identifies physiological factors like age, sex, pregnancy and food; pathological factors like liver and kidney disease; genetic factors; and environmental factors like route of administration and disease conditions as influencing drug response. It also covers drug interactions, noting that some drug combinations can produce synergistic or additive effects while others result in antagonism where the drugs oppose each other's actions. Understanding these modifying factors is important for choosing the appropriate drug and dose for each individual patient.
TEST BANK FOR Health Assessment in Nursing 7th Edition by Weber Chapters 1 - ...rightmanforbloodline
TEST BANK FOR Health Assessment in Nursing 7th Edition by Weber Chapters 1 - 34.
TEST BANK FOR Health Assessment in Nursing 7th Edition by Weber Chapters 1 - 34.
TEST BANK FOR Health Assessment in Nursing 7th Edition by Weber Chapters 1 - 34.
Sectional dentures for microstomia patients.pptxSatvikaPrasad
Microstomia, characterized by an abnormally small oral aperture, presents significant challenges in prosthodontic treatment, including limited access for examination, difficulties in impression making, and challenges with prosthesis insertion and removal. To manage these issues, customized impression techniques using sectional trays and elastomeric materials are employed. Prostheses may be designed in segments or with flexible materials to facilitate handling. Minimally invasive procedures and the use of digital technologies can enhance patient comfort. Education and training for patients on prosthesis care and maintenance are crucial for compliance. Regular follow-up and a multidisciplinary approach, involving collaboration with other specialists, ensure comprehensive care and improved quality of life for microstomia patients.
The facial nerve, also known as cranial nerve VII, is one of the 12 cranial nerves originating from the brain. It's a mixed nerve, meaning it contains both sensory and motor fibres, and it plays a crucial role in controlling various facial muscles, as well as conveying sensory information from the taste buds on the anterior two-thirds of the tongue.
Hypertension and it's role of physiotherapy in it.Vishal kr Thakur
This particular slides consist of- what is hypertension,what are it's causes and it's effect on body, risk factors, symptoms,complications, diagnosis and role of physiotherapy in it.
This slide is very helpful for physiotherapy students and also for other medical and healthcare students.
Here is summary of hypertension -
Hypertension, also known as high blood pressure, is a serious medical condition that occurs when blood pressure in the body's arteries is consistently too high. Blood pressure is the force of blood pushing against the walls of blood vessels as the heart pumps it. Hypertension can increase the risk of heart disease, brain disease, kidney disease, and premature death.
End-tidal carbon dioxide (ETCO2) is the level of carbon dioxide that is released at the end of an exhaled breath. ETCO2 levels reflect the adequacy with which carbon dioxide (CO2) is carried in the blood back to the lungs and exhaled.
Non-invasive methods for ETCO2 measurement include capnometry and capnography. Capnometry provides a numerical value for ETCO2. In contrast, capnography delivers a more comprehensive measurement that is displayed in both graphical (waveform) and numerical form.
Sidestream devices can monitor both intubated and non-intubated patients, while mainstream devices are most often limited to intubated patients.
Get Covid Testing at Fit to Fly PCR TestNX Healthcare
A Fit-to-Fly PCR Test is a crucial service for travelers needing to meet the entry requirements of various countries or airlines. This test involves a polymerase chain reaction (PCR) test for COVID-19, which is considered the gold standard for detecting active infections. At our travel clinic in Leeds, we offer fast and reliable Fit to Fly PCR testing, providing you with an official certificate verifying your negative COVID-19 status. Our process is designed for convenience and accuracy, with quick turnaround times to ensure you receive your results and certificate in time for your departure. Trust our professional and experienced medical team to help you travel safely and compliantly, giving you peace of mind for your journey.www.nxhealthcare.co.uk
Emotional and Behavioural Problems in Children - Counselling and Family Thera...PsychoTech Services
A proprietary approach developed by bringing together the best of learning theories from Psychology, design principles from the world of visualization, and pedagogical methods from over a decade of training experience, that enables you to: Learn better, faster!
4. “Tolerance is actually requirement of high dose of
prescribed drug in order to produce a
therapeutic response or action after it is being used
repeatedly.”
Drug Tolerance
6. Tolerance developed when an organism or species is inherited to
show low response or less sensitive to a specific agent or drug.
Example:
Negros or black people are less sensitive to mydriatic drugs
Natural/ Innate Tolerance
7. Tolerance developed in a person with repeated and constant
dose of drug although the person was initially responsive to the
particular dose of drug.
Example: Development of tolerance with drugs
use for CNS depression
Acquired Tolerance
8. Tachyphylaxis
The spontaneous decline in drug action with repeated
administration of agonist or repeated application of drug on same
dose. Drug is administered continuously after short interval of time
and clinical effects diminish
Example
Acute tolerance of cocaine and alcohol develop as if we administer
same dose it will not provide similar effect with the dose as
previous so we have to increase the dose to get the effects.
9. The tolerance against a specific drug develops through constant
use of alternative drug with similar pharmacological action.
Cross Tolerance
Example Morphine× Barbiturates and Ethanol × Nicotine
10. Functional tolerance develop if reactivity of site of action or
receptor of drug reduces. During Functional tolerance number of
receptor requires for drug action reduces or drug efficiency to bind
the receptor reduces as a result receptor become less responsive to
the drugs.
Example
Functional tolerance or lorazepam and alcohol has been observe
after long term exposure to rats and Mice
Pharmacodynamic Tolerance
Functional Tolerance
11. Change in process that may lead to reduction of drug reaching to site
of action,via any of pharmacokinetic parameter changes (ADME
chnages) this may be develop by increasing drug 1st pass metabolism
by increasing liver enzyme or somehow by enzyme activators that
result in excessive 1st pass metabolism as a results drugs can’t
absorb or distribute towards their site of action.
Pharmacodynamic Tolerance
Dispositional tolerance
MetabolicTolerance
13. Types of Drug Dependence
Physical Dependence
Psychological Dependence
14. Physical Dependence
When a person stops using a drug, their body goes through
withdrawal.Withdrawal symptoms are the group of
physical and mental symptoms that can range from
mild (for e.g. if the drug is caffeine) to life threatening (such
as opioids including heroin and prescription pain relievers
or alcohol)
15. Physical Dependence types currently recognized and
their clinical features:
Morphine (Restlessness, rubbing the face and body, irritability, yawning,
salivation, apprehension, nausea, vomiting, abdominal cramps, tremors,
diarrhea and in later stages elevated blood pressure, raised blood sugar)
Tobacco (Physcomotor , sleep and ECG change)
Ethanol (Abstinence syndrome)
Barbiturate/sedative type (barbiturates, meprobamate)anxiety,
insomnia, anorexia, nausea , vomiting, muscle twitching , delirium and
convulsions.
17. Psychological Dependence/addiction
New Defination
Substance use disorder (SUD) is a complicated
psychological illness in which a person impulsively
consumes substances such as alcohol, tobacco, and
illegal drugs despite being aware of the harmful
consequences.
18. Substances are divided into seven categories
based on their behavioral and psychological
effects
Nicotine
Alcohol
Cannabis
Opioids
Stimulants
Hallucinogens